A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 47.65%. However, over the past six months, we’ve seen a weaker performance of 151.34%. The price of OCUL leaped by -32.11% over the last 30 days. And in the last five days, it has fallen by -20.47%.
Ocular Therapeutix Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $11.31 on 03/06/24, with the lowest value being $2.00 on 11/10/23.
52-week price history of OCUL Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Ocular Therapeutix Inc’s current trading price is -41.78% away from its 52-week high, while its distance from the 52-week low is 230.08%. The stock’s price range for this period has been between $2.00 and $11.31. The Healthcare sector company’s shares saw a trading volume of about 2.4 million for the day, which was higher than the average daily volume of 2.07 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Ocular Therapeutix Inc (OCUL) has experienced a quarterly rise of 67.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 978.73M and boasts a workforce of 267 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.34, with a change in price of +4.47. Similarly, Ocular Therapeutix Inc recorded 1,876,539 in trading volume during the last 100 days, posting a change of +200.22%.
OCUL’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for OCUL stands at 0.92. Similarly, the long-term debt-to-equity ratio is also 0.90.
OCUL Stock Stochastic Average
As of today, the raw stochastic average of Ocular Therapeutix Inc over the last 50 days is at 27.32%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 7.36%. Further, the company’s Stochastic %K and %D values for the last 20 days were 6.44% and 8.09%, respectively.
